Advances in Small Animal Ophthalmic Surgery

A special issue of Animals (ISSN 2076-2615). This special issue belongs to the section "Veterinary Clinical Studies".

Deadline for manuscript submissions: closed (31 October 2022) | Viewed by 3098

Special Issue Editors


E-Mail Website
Guest Editor
Department of Veterinary Medicine and Animal Production, University of Naples Federico II, Via Federico Delpino 1, 80137 Napoli, Italy
Interests: veterinary surgery; veterinary ophthalmology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Veterinary Medicine and Animal Production, University of Naples Federico II, Via Federico Delpino 1, 80137 Napoli, Italy
Interests: veterinary surgery; veterinary oncology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Veterinary Medicine and Animal Production, University of Naples Federico II, Via Federico Delpino 1, 80137 Napoli, Italy
Interests: veterinary surgery; equine medicine
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues, 

In recent decades, all veterinary clinical specialties have been characterized by advances in knowledge and improvement in treatment. Among these specialties, ophthalmology has experienced dramatic progress. The development of veterinary ophthalmic surgery in recent years, in particular, has given rise to innovative research, advanced surgical skills and quality results for the recovery of animals’ visual function. The aim of this Special Issue is to clarify recent advances in the surgical management of many ophthalmic disorders in small animals, focusing on the latest surgical techniques and instrument technology. Moreover, all the most innovative techniques for the treatment of neoplastic diseases involving ocular tissues will be explored, in order to define the possibility of guaranteeing small animals a good quality of life, despite the invasiveness of ocular disease. In summary, this Special Issue will provide an overview of selected new developments in small animal ophthalmic surgery, opening avenues for new approaches to the therapies of many ocular pathologies found in clinical practice.

Prof. Dr. Barbara Lamagna
Prof. Dr. Luigi Navas
Prof. Dr. Maria Pia Pasolini
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Animals is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • small animals
  • ophthalmic surgery
  • veterinary ophthalmology
  • ocular oncology
  • microsurgery

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

13 pages, 10640 KiB  
Article
Lamellar Keratoplasty Using Acellular Bioengineering Cornea (BioCorneaVetTM) for the Treatment of Feline Corneal Sequestrum: A Retrospective Study of 62 Eyes (2018–2021)
by Huihao Xu, John S. Sapienza, Yipeng Jin, Jiahao Lin, Xiaobo Zheng, Haodi Dong, Hongxiu Diao, Ying Zhao, Jiafeng Gao, Jing Tang, Xueqian Feng, Danielle Micceri, Haoran Zeng and Degui Lin
Animals 2022, 12(8), 1016; https://doi.org/10.3390/ani12081016 - 13 Apr 2022
Cited by 3 | Viewed by 2248
Abstract
To retrospectively evaluate the effectiveness and outcome of lamellar keratoplasty using acellular bioengineering cornea (BioCorneaVetTM) for the treatment of feline corneal sequestrum (FCS). The medical records of cats diagnosed with FCS that underwent lamellar keratoplasty with BioCorneaVetTM between 2018 and [...] Read more.
To retrospectively evaluate the effectiveness and outcome of lamellar keratoplasty using acellular bioengineering cornea (BioCorneaVetTM) for the treatment of feline corneal sequestrum (FCS). The medical records of cats diagnosed with FCS that underwent lamellar keratoplasty with BioCorneaVetTM between 2018 and 2021 with a minimum of 3 months of follow-up were reviewed. Follow-up examinations were performed weekly for 3 months, and then optical coherence tomography (OCT) examination was performed on select patients at 0, 3, 6, and 12 months post-operatively. A total of 61 cats (30 left eyes and 32 right eyes) were included. The Persian breed was overrepresented, 48/61 (78.69%). Four different thicknesses of acellular bioengineering cornea were used (200, 300, 400, or 450 microns), and the mean graft size was 8.23 mm (range, 5.00–12.00 mm). Minor complications were composed of partial dehiscence, and protrusion of the graft occurred in 7/62 eyes (11.29%). The median postoperative follow-up was 12.00 months (range, 3–41 months). A good visual outcome was achieved in 60/62 eyes (96.77%), and a mild to moderate corneal opacification occurred in 2/62 (3.23%). No recurrence of corneal sequestrum was observed. From the results, lamellar keratoplasty using acellular bioengineering cornea (BioCorneaVetTM) is an effective treatment for FCS, providing a good tectonic support and natural collagen framework, and resulting in satisfactory visual and cosmetic effects. Full article
(This article belongs to the Special Issue Advances in Small Animal Ophthalmic Surgery)
Show Figures

Figure 1

Back to TopTop